Literature DB >> 20090311

Leukocyte toll-like receptor expression in end-stage kidney disease.

P Gollapudi1, J-W Yoon, S Gollapudi, M V Pahl, N D Vaziri.   

Abstract

BACKGROUND: End-stage renal disease (ESRD) is simultaneously associated with inflammation, impaired immunity and increased susceptibility to microbial infections. Innate immune cells, monocytes and polymorphonuclear leukocytes (PMN) recognize pathogens via toll-like receptors (TLR) triggering phagocytosis, cellular activation and secretion of inflammatory cytokines. Data on expression and function of TLRs in ESRD are limited.
METHODS: Blood samples from 21 stable ESRD patients and 21 normal controls were processed for TLR2, TLR4, TLR7 and TLR 9 expression on monocytes and PMN by flow cytometry. TLR activity was examined by determining the response to TLR4 and TLR2 ligands.
RESULTS: The ESRD group exhibited significant upregulation of TLR2 and TLR4 (but not TLR7 or TLR 9) expressions on monocytes and of TLR4 on PMN. This was coupled with heightened cytokine production in response to TLR4 activation with lipopolysaccharide. However, the response to TLR2 stimulation with peptidoglycan was unchanged in the ESRD group.
CONCLUSIONS: Monocyte TLR2 and TLR4 and neutrophil TLR4 expressions and TLR4 activity are increased hemodialysis patients, representing another dimension of ESRD-associated inflammation. 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20090311     DOI: 10.1159/000276764

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  35 in total

1.  Decreased number of CD14+TLR4+ monocytes and their impaired cytokine responses to lipopolysaccharide in patients with chronic kidney disease.

Authors:  Zhi Liu; Yan-Hong Kan; Yu-Dan Wei; Xiu-Jiang Li; Fan Yang; Yue Hou; Yu-Jun Du
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-04-16

Review 2.  Prophylactic vaccinations in chronic kidney disease: Current status.

Authors:  Alicja E Grzegorzewska
Journal:  Hum Vaccin Immunother       Date:  2015-04-27       Impact factor: 3.452

Review 3.  Effect of uremia on structure and function of immune system.

Authors:  Nosratola D Vaziri; Madeleine V Pahl; Albert Crum; Keith Norris
Journal:  J Ren Nutr       Date:  2012-01       Impact factor: 3.655

4.  Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC.

Authors:  Jayanta Gupta; Nandita Mitra; Peter A Kanetsky; Joe Devaney; Maria R Wing; Muredach Reilly; Vallabh O Shah; Vaidyanathapura S Balakrishnan; Nicolas J Guzman; Matthias Girndt; Brian G Periera; Harold I Feldman; John W Kusek; Marshall M Joffe; Dominic S Raj
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-27       Impact factor: 8.237

5.  Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation.

Authors:  Nosratola D Vaziri; Jun Yuan; Ardeshir Rahimi; Zhenmin Ni; Hyder Said; Veedamali S Subramanian
Journal:  Nephrol Dial Transplant       Date:  2011-11-29       Impact factor: 5.992

6.  Primed monocytes: putative culprits of chronic low-grade inflammation and impaired innate immune responses in patients on hemodialysis.

Authors:  Hye Won Kim; Young Seok Woo; Ha Na Yang; Hye Min Choi; Sang Kyung Jo; Won Yong Cho; Hyoung-Kyu Kim
Journal:  Clin Exp Nephrol       Date:  2010-12-09       Impact factor: 2.801

Review 7.  Atherosclerosis in chronic kidney disease: the role of macrophages.

Authors:  Valentina Kon; MacRae F Linton; Sergio Fazio
Journal:  Nat Rev Nephrol       Date:  2010-11-23       Impact factor: 28.314

8.  Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease.

Authors:  Nosratola D Vaziri; Jun Yuan; Keith Norris
Journal:  Am J Nephrol       Date:  2012-12-19       Impact factor: 3.754

Review 9.  Immune cell dysfunction and inflammation in end-stage renal disease.

Authors:  Michiel G H Betjes
Journal:  Nat Rev Nephrol       Date:  2013-03-19       Impact factor: 28.314

10.  Knockout of TRPV1 Exacerbates Ischemia-reperfusion-induced Renal Inflammation and Injury in Obese Mice.

Authors:  Beihua Zhong; Shuangtao Ma; Donna H Wang
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.